Target Name: SLC44A1
NCBI ID: G23446
Other Name(s): CDw92 | CD92 protein | OTTHUMP00000021838 | CDW92 antigen | CONATOC | CHTL1 | Solute carrier family 44 member 1, transcript variant 1 | RP11-287A8.1 | CTL1 | CD92 | solute carrier family 44 member 1 | CDW92 | solute carrier family 44 (choline transporter), member 1 | Choline transporter-like protein 1 (isoform a) | CTL1_HUMAN | Choline transporter-like protein 1 | Solute carrier family 44 member 1 | SLC44A1 variant 1

SLC44A1: A Potential Drug Target for Various Diseases

SLC44A1 (CDw92) is a protein that is expressed in various tissues throughout the body. It is a member of the SLC family, which is known for its ability to transport various molecules across cell membranes. One of the unique features of SLC44A1 is its ability to interact with the drug drug targets, such as wnt, sonic hedgehog, and retinoic acid.

SLC44A1 has been identified as a potential drug target due to its role in the development and progression of various diseases, including cancer. It has been shown to be involved in the regulation of cell proliferation, differentiation, and survival.

SLC44A1 has also been shown to play a role in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. It has been shown to be involved in the regulation of neurotransmitter synthesis and release, as well as the maintenance of the integrity of the blood-brain barrier.

In addition to its role in the nervous system, SLC44A1 has also been shown to be involved in the regulation of inflammation and immune responses. It has been shown to play a role in the regulation of cytokine production and the modulation of immune cell function.

SLC44A1 has also been shown to be involved in the regulation of protein synthesis and degradation, as well as cell signaling pathways. It has been shown to play a role in the regulation of cell adhesion, migration, and the transformation of normal cells into cancer cells.

In conclusion, SLC44A1 is a protein that has been shown to be involved in a wide range of biological processes that are important for the development and progression of various diseases. As a potential drug target, SLC44A1 is a promising target for the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of SLC44A1 in disease and to develop effective treatments.

Protein Name: Solute Carrier Family 44 Member 1

Functions: Choline transporter. Involved in membrane synthesis and myelin production

More Common Targets

SLC44A2 | SLC44A3 | SLC44A3-AS1 | SLC44A4 | SLC44A5 | SLC45A1 | SLC45A2 | SLC45A3 | SLC45A4 | SLC46A1 | SLC46A2 | SLC46A3 | SLC47A1 | SLC47A1P2 | SLC47A2 | SLC48A1 | SLC49A3 | SLC49A4 | SLC4A1 | SLC4A10 | SLC4A11 | SLC4A1AP | SLC4A2 | SLC4A3 | SLC4A4 | SLC4A5 | SLC4A7 | SLC4A8 | SLC4A9 | SLC50A1 | SLC51A | SLC51B | SLC52A1 | SLC52A2 | SLC52A3 | SLC5A1 | SLC5A10 | SLC5A11 | SLC5A12 | SLC5A2 | SLC5A3 | SLC5A4 | SLC5A4-AS1 | SLC5A5 | SLC5A6 | SLC5A7 | SLC5A8 | SLC5A9 | SLC66A1 | SLC66A1L | SLC66A2 | SLC66A3 | SLC6A1 | SLC6A1-AS1 | SLC6A10P | SLC6A10PB | SLC6A11 | SLC6A12 | SLC6A13 | SLC6A14 | SLC6A15 | SLC6A16 | SLC6A17 | SLC6A18 | SLC6A19 | SLC6A2 | SLC6A20 | SLC6A3 | SLC6A4 | SLC6A5 | SLC6A6 | SLC6A7 | SLC6A8 | SLC6A9 | SLC7A1 | SLC7A10 | SLC7A11 | SLC7A11-AS1 | SLC7A13 | SLC7A14 | SLC7A2 | SLC7A3 | SLC7A4 | SLC7A5 | SLC7A5P1 | SLC7A5P2 | SLC7A6 | SLC7A6OS | SLC7A7 | SLC7A8 | SLC7A9 | SLC8A1 | SLC8A1-AS1 | SLC8A2 | SLC8A3 | SLC8B1 | SLC9A1 | SLC9A2 | SLC9A3 | SLC9A3-AS1